Press Releases about Moderna Inc
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
Moderna Announces First Participant Dosed in Phase 2 Study of Omicron-Specific Bivalent Booster Candidate
March 10, 2022
From Moderna, Inc.
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
From Moderna, Inc.
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
Moderna Announces Its Global Public Health Strategy
March 07, 2022
From Moderna, Inc.
Via AccessWire
Topics
Intellectual Property
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
From Moderna, Inc.
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
From Moderna, Inc.
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
Moderna to Present at Upcoming Conferences in March 2022
March 02, 2022
From Moderna, Inc.
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
![](https://mms.businesswire.com/media/20220222006242/en/1368335/4/moderna-logo-1632484439.jpg)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
Moderna Expands Global Footprint Through Commercial Partnership with Adium in Latin America
February 22, 2022
From Moderna, Inc.
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
From Moderna, Inc.
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
Moderna Expands Its mRNA Pipeline with Three New Development Programs
February 18, 2022
From Moderna, Inc.
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
Therapeutic Goods Administration of Australia Authorizes Moderna's Covid-19 Vaccine in Children (6-11 Years)
February 16, 2022
From Moderna, Inc.
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
Moderna Announces Plan to Expand Footprint in Asia with Four Additional Subsidiaries
February 15, 2022
From Moderna, Inc.
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
Moderna Chief Technical Operations and Quality Officer Juan Andres Elected to National Academy of Engineering
February 09, 2022
From Moderna, Inc.
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
Moderna Announces New Supply Agreement with Colombia for Additional 10.8 Million Doses of Moderna's COVID-19 Vaccine
February 08, 2022
From Moderna, Inc.
Via AccessWire
Exposures
COVID-19
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
From Moderna, Inc.
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
IAVI and Moderna Launch Trial of HIV Vaccine Antigens Delivered Through mRNA Technology
January 27, 2022
From Moderna, Inc.
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
From Moderna, Inc.
Via AccessWire
![](https://storage.googleapis.com/accesswire/logos/subaccounts/share/30017.png?v=1)
Moderna Announces Advances Across Its Industry-Leading mRNA Pipeline and Provides Business Update
January 10, 2022
From Moderna, Inc.
Via AccessWire
Exposures
COVID-19
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.